Gara Jalqabaatti › Dhukkubaa Harkaa Steatotic › Texas › San Antonio
Qorannoo klinikaalii Dhukkubaa Harkaa Steatotic San Antonio, TX keessatti
Qorannoo 17 Dhukkubaa Harkaa Steatotic f San Antonio fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Namoota walitti qabaa jiraSadarkaa 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Namoota walitti qabaa jiraSadarkaa 3
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- 89bio Clinical Study Site, San Antonio
- fi 2 dabalataa
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Namoota walitti qabaa jiraSadarkaa 2
- American Research Corporation at The Texas Liver Institute, San Antonio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Namoota walitti qabaa jiraSadarkaa 2
- American Research Corporation at The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research - San Antonio, San Antonio
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Namoota walitti qabaa jiraSadarkaa 3
- American Research Corporation at Texas Liver Institute, San Antonio
- Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
- IMA Clinical Research San Antonio, San Antonio
- fi 1 dabalataa
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Namoota walitti qabaa jiraSadarkaa 3
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- Akero Clinical Study Site, San Antonio
- fi 2 dabalataa
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Namoota walitti qabaa jiraSadarkaa 2
- Quality Research, Inc., San Antonio
- Pinnacle Clinical Research - South San Antonio, San Antonio
- Pinnacle Clinical Research, San Antonio
Quantifying Hepatic Mitochondrial Fluxes in Humans
Namoota walitti qabaa jiraSadarkaa 4
- Texas Diabetes Institute - University Health System, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Namoota walitti qabaa jiraSadarkaa 2
- GSK Investigational Site, San Antonio
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Namoota walitti qabaa jiraSadarkaa 2
- GSK Investigational Site, San Antonio
- GSK Investigational Site, San Antonio
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Namoota walitti qabaa jiraSadarkaa 1
- GSK Investigational Site, San Antonio
Evaluating the Pharmacokinetics and Safety of Miricorilant
Namoota walitti qabaa jiraSadarkaa 1
- Site# 433, San Antonio
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- Endeavor Clinical Trials, San Antonio
Qorannoo Dhukkubaa Harkaa Steatotic magaalota biroo keessatti
- New York City, NYQorannoo 16
- Miami, FLQorannoo 16
- San Diego, CAQorannoo 14
- Austin, TXQorannoo 13
- Houston, TXQorannoo 13
- Richmond, VAQorannoo 12
- Tucson, AZQorannoo 10
- Chandler, AZQorannoo 10
- Hialeah, FLQorannoo 9
- Dallas, TXQorannoo 9
- Orlando, FLQorannoo 9
- St. Louis, MOQorannoo 9
Qorannoo biroo San Antonio keessatti
- Kansara Qara'a Non-Small CellQorannoo 59
- Saree OljooQorannoo 47
- Kansarii ColorectalQorannoo 46
- Kansara MetastatikiiQorannoo 44
- Saree (Gosoota Hunda)Qorannoo 41
- ObesityQorannoo 40
- Sukkaraa Gosa 2Qorannoo 37
- Baayyee UlfaataaQorannoo 34
- Kansarii OvariiQorannoo 31
- Kansarii PancreasQorannoo 31
- Kansarii ProstateQorannoo 28
- Kansa EndometiriyaaliiQorannoo 27
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.